ABCL Research and Charts

ABCL - AbCellera Biologics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2025-02-03 (Delayed quote data 2026-02-10)

Last 3.16	Change ⇓ -0.06 (-1.86%)	Volume 1,922,333
	Open 3.25	High 3.27	Low 3.14

8EMA (Daily) 3.32	40EMA (Daily) 3.76	50EMA (Daily) 3.82	STO (Daily) 13.649	MACD Hist (Daily) -0.082
8EMA (Weekly) 3.620	40EMA (Weekly) 3.85	50EMA (Weekly) 3.82	STO (Weekly) 21.972	MACD Hist (Weekly) -0.090


Company Profile
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes, and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.